AMERSIN LIFE SCIENCES CORPORATION (FORMERLY HUBEI - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/125247.xml AMERSIN LIFE SCIENCES CORPORATION (FORMERLY HUBEI - Press Releases en xml@emediawire.com xml@emediawire.com 30 Amersin Subsidiary Receives 30 Million RMB Contract http://www.prweb.com/releases/2005/04/prweb225886.htm Amersin Life Science Corporation announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million RMB sales contract (approx. 3.6 million USD) to supply a range of homeostatic, antiviral and other pharmaceuticals in injectable form to Hubei Jiuzhoutong Pharmaceutical Ltd. (PRWeb Apr 6, 2005)

Read the full story at http://www.prweb.com/releases/2005/04/prweb225886.htm

]]> http://www.prweb.com/releases/2005/04/prweb225886.htm Amersin Announces 30% Increase in Ribavirin Production to Meet Market Demand Following Recent Avian Flu Outbreaks in Asia http://www.prweb.com/releases/2005/01/prweb202961.htm Amersin is a public company listed on the US OTCBB under the trading symbol AMLS and in Germany on the Frankfurt Exchange under the trading symbol HUQ. Its subsidiary is increasing production of the antiviral Ribavirin in response to market demand created, in part, by recent human cases of avian influenza (H5N1). (PRWeb Jan 30, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb202961.htm

]]> http://www.prweb.com/releases/2005/01/prweb202961.htm Amersin Life Sciences Announces Contract with China’s International Tsunami Relief Program http://www.prweb.com/releases/2005/01/prweb200917.htm Amersin, a public American holding company, supplies pharmaceuticals for Sri Lanka tsunami relief program under 6.4 million RMB contract through its Chinese subsidiary. (PRWeb Jan 24, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb200917.htm

]]> http://www.prweb.com/releases/2005/01/prweb200917.htm Amersin Life Sciences Corporation Announces New Trading Symbol and Completion of Name Change http://www.prweb.com/releases/2005/01/prweb197804.htm Amersin Life Sciences Corporation (formerly Hubei Pharmaceutical Group Ltd. OTCBB:HBEI, CUSIP 44352P106) announced today that it has completed its name change and been assigned a new trading symbol and CUSIP number. (PRWeb Jan 18, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb197804.htm

]]> http://www.prweb.com/releases/2005/01/prweb197804.htm